China overtakes US as Germany’s top trading partner, and it’s a pretty big deal. It’s a shift that’s getting a lot of attention, and for good reason. It signals a changing of the guard, a re-evaluation of global alliances, and a potential realignment of economic power. So, let’s unpack it.
The immediate reaction for some is a kind of schadenfreude, a “told you so” directed at the U.S. There’s a narrative that America has become, well, less desirable as a trading partner. The sentiment is that the U.S. wants to “produce” everything for itself again, seemingly retreating from its historical role as a global trading powerhouse.… Continue reading
Brazil’s soybean exports are poised to hit a record high, an interesting situation is brewing, and it’s primarily driven by the fact that the US is largely out of the market. This creates a significant opportunity for Brazil, especially with strong demand coming from China. It’s like a perfect storm for Brazilian farmers, isn’t it? They are in a prime position to capitalize on a shift in the global soybean trade.
The shift in demand is a crucial piece of the puzzle. With the US facing challenges in the market, and the tariffs against China, the soybean market dynamics have changed.… Continue reading
Under Trump, US cedes its share of China’s beef market to Australia. It’s fascinating, isn’t it, how shifts in global trade can happen so quickly? I mean, one minute the US beef industry is chugging along, and the next… well, the Aussies are suddenly doing a lot of winning. And we’re talking big numbers – an $80 million per month swing in beef exports, all thanks to a series of events that played out under the Trump administration.
The story really begins with tariffs. When Trump decided to impose tariffs on Chinese imports, China, naturally, retaliated. And one of the first things they did was significantly curb their imports of US beef.… Continue reading
The United States has ended the de minimis rule, which previously allowed low-value imported goods to enter duty-free. As of a specific time, all imported goods, regardless of value, are now subject to tariffs ranging from 10% to 50%, potentially impacting prices for consumers. Delivery services globally had already begun making adjustments, with some suspending services while others anticipate delays. While this change could increase costs for some shoppers, it could also level the playing field for some American small businesses by reducing the competitive advantage of foreign e-commerce giants who had benefited from the exemption.
Read More
The European Commission President floated a plan for the EU and the Comprehensive and Progressive Agreement for Trans-Pacific Partnership (CPTPP) to form a new global trade initiative. This initiative would overhaul the rules-based global trading order, potentially supplanting the World Trade Organization, with the United States not guaranteed an invitation. The proposal aims to demonstrate the viability of free trade among a large group of countries based on a strong foundation of rules. The President also noted that the U.S. left a certain point.
Read More
The World Bank forecasts the slowest decade of global growth since the 1960s, with 2025 growth projected at only 2.3% and 2027 at 2.6%, significantly lower than previous estimates. This downward revision, impacting nearly two-thirds of countries, is largely attributed to escalating trade tensions, particularly stemming from US tariffs. The US forecast was downgraded due to these tensions and their impact on investor confidence and consumption, while China’s forecast remained stable due to its perceived resilience. Further tariff increases, the report warns, could lead to a global trade slowdown and increased market uncertainty.
Read More
Facing a July 8th deadline for its “90 deals in 90 days” initiative, the Trump administration sent letters urging countries to submit their best trade offers. These letters, a “friendly reminder” according to the press secretary, follow the April pause on new tariffs. However, the need for such reminders has sparked skepticism, with critics questioning the administration’s claims of successful negotiations and the likelihood of meeting the ambitious goal. Social media users have highlighted the shift from assertive pronouncements to what they perceive as pleading with trading partners.
Read More
President Trump doubled steel import tariffs to 50%, prompting immediate condemnation from the European Union, which threatened retaliatory measures unless a negotiated solution is found by July 14. The EU cited increased costs for consumers and businesses, while the United Steelworkers union criticized the impact on Canadian jobs. Trump, announcing the tariff increase at a U.S. Steel rally, claimed a pending deal with Nippon Steel would prevent job losses, though the deal remains unfinalized. This action follows a recent court ruling that temporarily halted many of Trump’s country-specific tariffs.
Read More
Walmart’s recent announcement of higher prices and its decision to withhold second-quarter profit guidance has sent ripples throughout the business world and beyond. This isn’t simply a matter of corporate strategy; it reflects a confluence of global economic factors that are impacting consumers’ wallets and raising concerns about broader economic stability.
The reasons behind Walmart’s price increases are multifaceted and complex. Supply chain disruptions, exacerbated by ongoing geopolitical tensions and the lingering effects of the pandemic, are undoubtedly playing a major role. The increasing cost of shipping containers, coupled with tariffs and sanctions, is making it significantly more expensive to import goods, many of which originate from China.… Continue reading
President Trump announced an executive order aiming to slash US prescription drug prices by 30-80%, potentially impacting global markets. This aggressive move involves pressuring European countries to increase their drug prices and threatening trade sanctions against uncooperative nations. The order seeks to lower prices to global minimums, forcing pharmaceutical companies to significantly reduce their profits and potentially reducing investment in research and development. This action is facing opposition from the pharmaceutical industry and analysts question its feasibility.
Read More
Matt Underwood 
John Q. Hosedrinker